Completed NA INTERVENTIONAL 3-arm
NCT05930002
Role of Ivermectin and Colchicine in Treatment of COVID-19: Randomized Controlled Clinical Trial
Sponsor: Ain Shams University
Conditions
COVID-19
Interventions
Colchicine 0.5 MG Ivermectin Tablets Standared managment
Updated 3 times since 2023 Last updated: Jul 2, 2023 Started: Jul 21, 2021 Primary completion: Sep 9, 2022 Completion: Dec 28, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A NA clinical study on COVID-19, this trial is completed. The trial is conducted by Ain Shams University and has accumulated 3 data snapshots since 2021. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
3 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Aug 2023 — Jul 2024 [monthly]
Completed NA
First recorded
Jul 2021
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Ain Shams University
Data source: Ain Shams University
For direct contact, visit the study record on ClinicalTrials.gov .